← Leaderboards
Leslie Tong
Gabaeron, Inc.
$1,822,632
Attributed
$3,645,264
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2018–20$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
Funding mix
By agency
NIH$3,645,264 · 2
By mechanism
R44$3,645,264 · 2
Top collaborators
- Robert W. Mahley5 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposPathway InteractionsGenetic Risk FactorLearningMemory ImpairmentNeuronsInduced Pluripotent Stem CellImpairmentKnock-InLeadAllelesApolipoprotein E-4MemoryNeurodegenerative DisordersAffectCellsCessation Of LifeHippocampus (Brain)DoseInterneuronsApolipoprotein EKnock-In MouseApolipoprotein E-3Protein Isoforms
Grant awards (5)
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease$1,079,582
R44 · FY2020 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4$948,584
R44 · FY2020 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4$982,084
R44 · FY2019 · AG
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease$342,592
R44 · FY2019 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4$292,422
R44 · FY2018 · AG